Study To Evaluate Long Term Treatment Effect Of Diapep277® In Patients Who Have Completed Study 901 And Study 910** (Extension To 901)

Hadassah Medical Center

Status and phase: Unknown; Phase 3

Conditions: Giving a Vaccination in Three Months

Treatments: Other: vaccine

Study type: Interventional

Funder types: Other

Identifiers

NCT01281072

911-DIAPEP277

Details and patient eligibility

About

Open label study to evaluate long term treatment effect of diapep277.

Sex: All

Ages: 20 to 50 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

1. patient that completed 901 and 910 study.

Exclusion criteria

1. cpeptide<0.2